ARTV

Artiva Biotherapeutics
ARTV

Overview Fund Trends Analyst Outlook Journalist POV

48 hedge funds and large institutions have $319M invested in Artiva Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$152M
2
+$36.4M
3
+$24.9M
4
VP
venBio Partners
California
+$23.5M
5
Capital World Investors
Capital World Investors
California
+$14.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$152M
2
$36.4M
3
$24.9M
4
$23.5M
5
$14.1M
6
$13M
7
$12.9M
8
$7.44M
9
$4.77M
10
$4.51M
11
$4.37M
12
$2.91M
13
$2.3M
14
$2.13M
15
$1.74M
16
$1.6M
17
$1.54M
18
$1.52M
19
$1.34M
20
$680K
21
$640K
22
$623K
23
$617K
24
$482K
25
$457K
1
2